Cerebrospinal fluid samples are analysed for the diagnosis of neurodegenerative diseases such as Alzheimer's disease. Various proteins such as Aβ and tau are analysed for their concentration. A typical Alzheimer's biomarker profile includes a decrease in Aβ1-42 and an increase in t-tau and p-tau.